Evolus (EOLS) Cash from Investing Activities (2018 - 2026)

Evolus (EOLS) posted Cash from Investing Activities of -$1.7 million for Q1 2026, up 21.93% on a QoQ basis from -$2.2 million in Q4 2025, and up 9.13% year-over-year from -$1.5 million in Q1 2025.

Evolus (EOLS) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Evolus' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$1.7 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 9.13% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.3 million (down 40.68% YoY) and the FY2025 annual result came in at -$8.5 million, down 75.24% from the prior year.
  • Cash from Investing Activities was -$1.7 million for Q1 2026 at Evolus, up from -$2.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$216000.0 in Q2 2023 and bottomed at -$2.3 million in Q2 2025.
  • A 5-year average of -$1.1 million and a median of -$1.3 million in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 4380.95% — and 2023, when it soared 74.05%.
  • Evolus' Cash from Investing Activities stood at -$1.4 million in 2022, then surged by 74.05% to -$361000.0 in 2023, then tumbled by 277.29% to -$1.4 million in 2024, then plunged by 59.03% to -$2.2 million in 2025, then grew by 21.93% to -$1.7 million in 2026.
  • Business Quant data shows EOLS's Cash from Investing Activities at -$1.7 million in Q1 2026, -$2.2 million in Q4 2025, and -$2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.60 Bn 87.73 Bn - -
2 Teva Pharmaceutical Industries 35.84 Bn 32.10 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.12 Bn 20.96 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.78 Bn 16.46 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn -60.00 Mn
10 Evolus 401.22 Mn 351.43 Mn 48.90 Mn -1.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.69 Mn
Mar 31, 2026 -1.69 Mn
Dec 31, 2025 -2.17 Mn
Dec 31, 2025 -2.17 Mn
Sep 30, 2025 -2.16 Mn
Sep 30, 2025 -2.16 Mn
Jun 30, 2025 -2.27 Mn
Jun 30, 2025 -2.27 Mn
Mar 31, 2025 -1.86 Mn
Mar 31, 2025 -1.86 Mn
Dec 31, 2024 -1.36 Mn
Dec 31, 2024 -1.36 Mn
Sep 30, 2024 -1.41 Mn
Sep 30, 2024 -1.41 Mn
Jun 30, 2024 -1.25 Mn
Jun 30, 2024 -1.25 Mn
Mar 31, 2024 -797,000.00
Mar 31, 2024 -797,000.00
Dec 31, 2023 -361,000.00
Dec 31, 2023 -361,000.00